Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
45
ACLS Quote, Financials, Valuation and Earnings
Last price:
$71.62
Seasonality move
:
4.32%
Day range:
$70.65 - $72.34
52-week range:
$40.40 - $138.74
Dividend yield:
0%
P/E ratio:
13.10x
P/S ratio:
2.43x
P/B ratio:
2.24x
Volume:
367.9K
Avg. volume:
571.1K
1-year change:
-46.92%
Market cap:
$2.3B
Revenue:
$1B
EPS (TTM):
$5.46
Analysts' Opinion
-
Consensus RatingAxcelis Technologies has received a consensus rating of Hold. The company's average rating is a Hold based on 2 Buy ratings, 5 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $72.75, Axcelis Technologies has an estimated upside of 1.72% from its current price of $71.52.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $68.00 representing 100% downside risk from its current price of $71.52.
Fair Value
-
According to the consensus of 7 analysts, Axcelis Technologies has 1.72% upside to fair value with a price target of $72.75 per share.
ACLS vs. S&P 500
-
Over the past 5 trading days, Axcelis Technologies has underperformed the S&P 500 by -6.02% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Axcelis Technologies does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Axcelis Technologies revenues have been falling on a year-over-year basis for 5 quarters in a row. In the most recent quarter Axcelis Technologies reported revenues of $192.6M.
Earnings Growth
-
Axcelis Technologies earnings have been falling on a year-over-year basis for 4 quarters in a row. In the most recent quarter Axcelis Technologies reported earnings per share of $0.88.
Enterprise value:
1.7B
EV / Invested capital:
--
Price / LTM sales:
2.43x
EV / EBIT:
8.15x
EV / Revenue:
1.79x
PEG ratio (5yr expected):
0.89x
EV / Free cash flow:
13.92x
Price / Operating cash flow:
18.96x
Enterprise value / EBITDA:
7.56x
Gross Profit (TTM):
$427.4M
Return On Assets:
13.44%
Net Income Margin (TTM):
18.58%
Return On Equity:
18.34%
Return On Invested Capital:
18.34%
Operating Margin:
15.14%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $970.4M | $1.1B | $958.1M | $252.4M | $192.6M | |
| Gross Profit | $416M | $503.3M | $427.4M | $116.1M | $88.8M | |
| Operating Income | $214.8M | $271M | $183.4M | $56.5M | $29.2M | |
| EBITDA | $229.2M | $303.8M | $226.2M | $64.1M | $38.8M | |
| Diluted EPS | $5.67 | $7.57 | $5.46 | $1.57 | $0.88 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $479.6M | $648.7M | $934.4M | $1.1B | $1.1B | |
| Total Assets | $629.3M | $782.2M | $1.1B | $1.3B | $1.3B | |
| Current Liabilities | $83.9M | $147.5M | $267.9M | $276.6M | $200.4M | |
| Total Liabilities | $141.6M | $222.9M | $378M | $404.9M | $313.4M | |
| Total Equity | $487.7M | $559.3M | $701.8M | $901.7M | $1B | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $224.4M | $164.5M | $138.4M | $42.2M | $39.8M | |
| Cash From Investing | -$288.8M | -$123.5M | -$12.6M | -$55.7M | $40.5M | |
| Cash From Financing | -$59.1M | -$69.7M | -$73.2M | -$18.1M | -$20.1M | |
| Free Cash Flow | $213M | $144.5M | $122.9M | $40.6M | $34.8M | |
ACLS
Sector
Market Cap
$2.3B
$83.5M
Price % of 52-Week High
51.55%
64.2%
Dividend Yield
0%
0%
Shareholder Yield
3.99%
0.68%
1-Year Price Total Return
-46.92%
-12.88%
Beta (5-Year)
1.569
0.814
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$73.18
200-day SMA
Buy
Level
$69.15
Bollinger Bands (100)
Buy
Level
50.24 - 67.8
Chaikin Money Flow
Buy
Level
17.2M
20-day SMA
Buy
Level
$71.20
Relative Strength Index (RSI14)
Buy
Level
55.51
ADX Line
Sell
Level
21.08
Williams %R
Neutral
Level
-62.3377
50-day SMA
Buy
Level
$65.53
MACD (12, 26)
Buy
Level
2.20
25-day Aroon Oscillator
Buy
Level
68
On Balance Volume
Neutral
Level
103.7M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (6.6729)
Buy
CA Score
(Annual)
Level (1.6279)
--
Beneish M-Score
(Annual)
Level (--)
Sell
Momentum Score
Level (2)
Buy
Ohlson Score
Level (-3.5138)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (6)
Buy
Fundamental Score
Level (8)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Axcelis Technologies Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips. In addition to equipment, the company provides aftermarket lifecycle products and services, including used tools, spare parts, equipment upgrades, maintenance services, and customer training. Geographically, the group has a business presence in North America, Asia Pacific, and Europe, of which key revenue is derived from the Asia Pacific.
Stock Forecast FAQ
In the current month, ACLS has received 2 Buy ratings 5 Hold ratings, and 0 Sell ratings. The ACLS average analyst price target in the past 3 months is $72.75.
-
Where Will Axcelis Technologies Stock Be In 1 Year?
According to analysts, the consensus estimate is that Axcelis Technologies share price will rise to $72.75 per share over the next 12 months.
-
What Do Analysts Say About Axcelis Technologies?
Analysts are divided on their view about Axcelis Technologies share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Axcelis Technologies is a Sell and believe this share price will drop from its current level to $68.00.
-
What Is Axcelis Technologies's Price Target?
The price target for Axcelis Technologies over the next 1-year time period is forecast to be $72.75 according to 7 Wall Street analysts, 2 of them rate the stock a Buy, 0 rate the stock a Sell, and 5 analysts rate the stock a Hold.
-
Is ACLS A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Axcelis Technologies is a Hold. 5 of 7 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of ACLS?
You can purchase shares of Axcelis Technologies via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Axcelis Technologies shares.
-
What Is The Axcelis Technologies Share Price Today?
Axcelis Technologies was last trading at $71.62 per share. This represents the most recent stock quote for Axcelis Technologies. Yesterday, Axcelis Technologies closed at $71.52 per share.
-
How To Buy Axcelis Technologies Stock Online?
In order to purchase Axcelis Technologies stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
93
EXOD alert for Jul 18
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
